During the past decade, California Pacific Medical Center Research Institute conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Pacific Medical Center Research Institute" #1 sponsor was "California Pacific Medical Center Research Institute" with 6 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Novartis Pharmaceuticals" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Pacific Medical Center Research Institute" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "California Pacific Medical Center Research Institute" are "Fallopian Tube Cancer" (3 trials), "Ovarian Cancer" (3 trials), "Aortic Regurgitation" (2 trials), "Basal Cell Carcinoma" (2 trials) and "Cystinosis" (2 trials). Many other conditions were trialed in "California Pacific Medical Center Research Institute" in a lesser frequency.

Most popular intervention types in "California Pacific Medical Center Research Institute" are "Drug" (31 trials), "Device" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Nivolumab" (4 trials), "Ipilimumab" (3 trials), "ASA404" (2 trials) and "Olaparib" (2 trials). Other intervention names were less common.

The vast majority of trials in "California Pacific Medical Center Research Institute" are 30 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "California Pacific Medical Center Research Institute". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in California Pacific Medical Center Research Institute, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in California Pacific Medical Center Research Institute, 3 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

California Pacific Medical Center Research Institute has several departments that took part in Clinical trials: "CPMC Addiction & Pharmacology Research Laboratory (APRL)" - 4 trials